Erasca Inc.

Last updated September 27, 2026

Organization details

Legal name
Erasca Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
SAN Diego
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
ERAS
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001761918
EIN
83-1217027

Board of directors

Chief executives

Jonathan E. Lim · Chairman & CEO
Dates unknown

Board connections

4 of this board's directors also sit on 8 other boards. 7 are in the same sector.

Network of Erasca Inc.'s board connections Biomea Fusion Inc. Biomea Fusion Inc. BlossomHill Therapeutics Inc. BlossomHill Therapeuti... Boundless Bio Inc. Boundless Bio Inc. BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology The... Connect Biopharma Holdings Limited Connect Biopharma Hold... Ernexa Therapeutics Inc. Ernexa Therapeutics In... Helix Acquisition Corp. III Helix Acquisition Corp... Maze Therapeutics Inc. Maze Therapeutics Inc. Bihua Chen Bihua Chen James Arthur Bristol James Arthur Bristol Jean I. Liu Jean I. Liu Jonathan E. Lim Jonathan E. Lim Erasca Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$2,283,600
3 sales by 2 insiders
Date Insider Transaction Shares Price Value
Apr 1, 2026 Garner Ebun Officer (Chief Legal Officer) Option exercise +80,000 $1.70 $136,000
Apr 1, 2026 Garner Ebun Officer (Chief Legal Officer) Open-market sale −80,000 $16.40 $1,312,000
Mar 4, 2026 Morris Shannon Officer (Chief Medical Officer) Option exercise +20,000 $1.70 $34,000
Mar 4, 2026 Morris Shannon Officer (Chief Medical Officer) Open-market sale −20,000 $15.04 $300,800
Jan 7, 2026 Garner Ebun Officer (General Counsel & Corp. Sec.) Option exercise +120,000 $1.70 $204,000
Jan 7, 2026 Garner Ebun Officer (General Counsel & Corp. Sec.) Open-market sale −120,000 $5.59 $670,800
Dec 15, 2025 Chacko David M. Officer (CFO and CBO) Other +17,793 $1.19 $21,174
Dec 15, 2025 Garner Ebun Officer (General Counsel & Corp. Sec.) Grant or award +3,902 $1.19 $4,643
May 23, 2025 Pratik S. Multani Director Gift −6,200 — —
May 23, 2025 Pratik S. Multani Director Gift +6,200 — —
Dec 13, 2024 Chacko David M. Officer (CFO and CBO) Other +12,324 $1.56 $19,225
Dec 13, 2024 Garner Ebun Officer (General Counsel & Corp. Sec.) Other +5,731 $1.56 $8,940
Jun 14, 2024 Chacko David M. Officer (CFO and CBO) Other +3,137 $1.56 $4,894
Jun 14, 2024 Garner Ebun Officer (General Counsel & Corp. Sec.) Other +5,715 $1.56 $8,915
May 21, 2024 Alexander W. Casdin Director Open-market purchase +80,000 $2.27 $181,600

Organizations in the same sector, closest in location and size first.

Questions about Erasca Inc.

Who is the CEO of Erasca Inc.?

Jonathan E. Lim is Erasca Inc.'s Chairman & CEO.

How many directors are on Erasca Inc.'s board?

Erasca Inc.'s board has 9 directors: Alexander W. Casdin, Bihua Chen, James Arthur Bristol, Jean I. Liu, Jonathan E. Lim, Julie Hambleton, Michael David Varney, Pratik S. Multani and Valerie Denise Harding Start.

Are Erasca Inc. insiders buying or selling shares?

Over the last 12 months, Erasca Inc. insiders made no open-market purchases and sold $2.3 million of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="erasca-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.